Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Progyny, Inc. (PGNY : NSDQ)
 
 • Company Description   
Progyny Inc. is a fertility benefits management company. It specializes in fertility and family building benefits solutions. Progyny Inc. is based in New York, United States.

Number of Employees: 680

 
 • Price / Volume Information   
Yesterday's Closing Price: $22.37 Daily Weekly Monthly
20 Day Moving Average: 1,811,506 shares
Shares Outstanding: 85.98 (millions)
Market Capitalization: $1,923.43 (millions)
Beta: 1.29
52 Week High: $26.57
52 Week Low: $13.39
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 11.29% 8.38%
12 Week -4.40% -8.37%
Year To Date 29.68% 13.35%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1359 BROADWAY
-
NEW YORK,NY 10018
USA
ph: 212-888-3124
fax: -
investors@progyny.com http://www.progyny.com
 
 • General Corporate Information   
Officers
Peter Anevski - Chief Executive Officer and Director
David Schlanger - Chairman
Mark Livingston - Chief Financial Officer
Debra Morris - Director
Lloyd Dean - Director

Peer Information
Progyny, Inc. (CHCR)
Progyny, Inc. (ESRX)
Progyny, Inc. (MYDP)
Progyny, Inc. (COR)
Progyny, Inc. (GBCS)
Progyny, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 74340E103
SIC: 8090
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/26/26
Share - Related Items
Shares Outstanding: 85.98
Most Recent Split Date: (:1)
Beta: 1.29
Market Capitalization: $1,923.43 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.14 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.71 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 16.64% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/26/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 31.66
Trailing 12 Months: 37.92
PEG Ratio: 1.90
Price Ratios
Price/Book: 3.43
Price/Cash Flow: 64.82
Price / Sales: 1.52
EPS Growth
vs. Year Ago Period: 36.36%
vs. Previous Quarter: -21.05%
Sales Growth
vs. Year Ago Period: 9.32%
vs. Previous Quarter: -5.87%
ROE
09/30/25 - 10.71
06/30/25 - 10.69
03/31/25 - 10.90
ROA
09/30/25 - 7.27
06/30/25 - 7.12
03/31/25 - 7.20
Current Ratio
09/30/25 - 2.95
06/30/25 - 2.70
03/31/25 - 2.39
Quick Ratio
09/30/25 - -
06/30/25 - 2.70
03/31/25 - 2.39
Operating Margin
09/30/25 - 4.14
06/30/25 - 3.96
03/31/25 - 4.00
Net Margin
09/30/25 - 4.46
06/30/25 - 4.28
03/31/25 - 4.33
Pre-Tax Margin
09/30/25 - 7.51
06/30/25 - 7.18
03/31/25 - 7.19
Book Value
09/30/25 - 6.51
06/30/25 - 6.01
03/31/25 - 5.45
Inventory Turnover
09/30/25 - -
06/30/25 - -
03/31/25 - -
Debt-to-Equity
09/30/25 - -
06/30/25 - 0.00
03/31/25 - 0.00
Debt-to-Capital
09/30/25 - -
06/30/25 - 0.00
03/31/25 - 0.00
 

Powered by Zacks Investment Research ©